MaxCyte, Inc.

MaxCyte's Flow Electroporation® technology enables efficient antibody discovery by mammalian display. Learn how how our technology has delivered greater sequence diversity and library coverage, enabling: • A simplified workflow with one-shot electroporation of up to 700 million cells • Reproducible transfection delivering consistent results • Discovery of better antibody candidates using fewer resources and less hands-on time. • MaxCyte’s Flow Electroporation technology can transfect up to 20 billion cells for mammalian display screening of large libraries for antibody discovery. #IgGplasmid #transfection #electroporation #mammaliandisplay #antibody https://bit.ly/3Uqr9hJ

Register for a virtual seminar on Wednesday, October 30, 2024 exploring innovative cell engineering methods, featuring guest speakers Steven Feldman,PhD Stanford University's Scientific Director of the Laboratory of Cell & Gene Medicine and Shigeki Yagyu, MD, PhD, a Pediatric Oncologist at Shinshu University. Listen as Dr. Feldman, and Dr. Yagyu share they leverage the MaxCyte platform to manufacture gene engineered products for patients. Attendees will learn how MaxCyte’s Flow Electroporation® technology efficiently engineers various cell types while ensuring high cell viability and optimal recovery rates for applications like CRISPR, cell-based assays, cell therapy manufacturing, and viral production. Register today! #CRISPR https://bit.ly/4hnkI8P

Are you interested in learning how MaxCyte’s advanced electroporation platforms are driving innovations in cell therapies, including the use of dendritic cells for next-generation vaccines and immunotherapies? Join us tomorrow for a lunch and learn seminar on high efficiency-cell engineering at ASU Biodesign Institute from 12:00 - 1:00 pm MT, featuring a presentation by Skylar Henry, Ph.D., Postdoctoral Research Scholar of Biodesign Center for Personalized Diagnostics. Explore how these technologies are unlocking new possibilities in precision medicine and improving therapeutic outcomes. This seminar will include lunch and an opportunity to gain insights from our team on how MaxCyte can help take your processes from concept all the way through commercialization! We are here to light the way towards your clinical successes. https://bit.ly/4dHOh1W

MaxCyte's Flow Electroporation® technology, supported by a global team of R&D and application scientists can help you to accelerate antibody development and production to bring new treatments to patients sooner. Learn how MaxCyte's Flow Electroporation® technology can help you to: • Transfect any cell • Transfect cells at any scale • Express any type of protein • Use the culture strategy you want • Conduct rapid transient antibody production • and more. https://bit.ly/3A66PeJ

Join us for a lunch and learn seminar on high-efficiency cell engineering at the Innovative Genomics Institute on Wednesday, November 13, 2024, from 12:00 - 1:00 pm PT. Featuring presentations from Kimberly Hu, and Ke Li, PhD discussing research focuses on understanding the pathogenesis of squamous cell carcinoma and merkel cell carcinoma, and integrating cutting-edge genome and epigenome engineering tools into non-viral platforms. Register now for an opportunity to explore the future of cellular engineering. Gain valuable insights into MaxCyte’s cutting-edge electroporation platforms, which enable the efficient engineering of primary cells, stem cells, and various other cell lines. #CRISPR #cellbasedassays #celltherapymanufacturing #viralproduction https://bit.ly/3YEEO7b

Register for a virtual seminar on Wednesday, October 30, 2024 exploring innovative cell engineering methods, featuring guest speakers Steven Feldman,PhD Stanford University's Scientific Director of the Laboratory of Cell & Gene Medicine and Shigeki Yagyu, MD, PhD, a Pediatric Oncologist at Shinshu University. Listen as Dr. Feldman, and Dr. Yagyu share they leverage the MaxCyte platform to manufacture gene engineered products for patients. Attendees will learn how MaxCyte’s Flow Electroporation® technology efficiently engineers various cell types while ensuring high cell viability and optimal recovery rates for applications like CRISPR, cell-based assays, cell therapy manufacturing, and viral production. Register today! #CRISPR https://bit.ly/4hnkI8P

Join MaxCyte, next Wednesday, October 30, 2024 for a seminar on high- efficiency cell engineering featuring a presentation by Skylar Henry, Ph.D., of the ASU Biodesign Institute who will discuss using dendritic cell for vaccine and therapeutic approaches. Register today and we look forward to seeing you there! https://bit.ly/4dHOh1W Kyle Franks

Connect with our team at #ESGCT2024! We invite you to visit us at booth B27 from 22-25, October. Our team is eager to discuss how we can assist in accelerating your cell therapy development from concept through commercialization. Engage with our experts and discover tailored solutions designed to meet your specific needs. We look forward to connecting with you. #celltherapy #genetherapy #electroporation https://bit.ly/48ecAn1 Geert Nobels Jelani Leito Miguel Jimenez Anna Otal Navarro Marie-Laure Joandel

Are you attending #ESGCT2024? Be sure to visit, Andrew Guy Mancini's poster presentation at #ESGCT2024, where he will delve into his research on high-efficiency, complex gene editing of challenging primary cells. He will highlight the use of MaxCyte electroporation alongside Synthego sgRNAs. We look forward to seeing you there! #celltherapy #genetherapy #electroporation https://bit.ly/48ecAn1

Today, visit Diwash Acharya, PhD during his poster presentation at #ESGCT2024, where he will discuss his work on optimizing CRISPR/Cas-Mediated CD-19 CAR knock-in efficiency, cell viability and cell expansion in human primary T cells using a cGMP-compliant electroporation platform. Be sure to stop by booth B27 to connect with our team to learn how our Flow Electroporation® technology can elevate your research and clinical breakthroughs. We look forward to seeing you there! #celltherapy #genetherapy #electroporation https://bit.ly/48ecAn1